SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " clinician " 247 found 🔀 AI-powered Shuffle
How one kidney care company built a solid AI foundation
Strive Health says its successes with artificial intelligence came from solving for fragmented data, embedding intelligence into clinicians' workflows and keeping providers at the center of care. It's showing up in improved outcomes.
FDA authorizes first AI tech for visualizing coronary inflammation in CT scans
Cardiac imaging experts have been anticipating this news for quite some time. The belief is that it could help transform how clinicians evaluate cardiovascular risk.
Kaiser used an algorithm — not clinicians — to triage mental health patients, a union alleges
A therapists' union alleges Kaiser's e-visit tool screens mental health patients and issues care recommendations without real-time clinician review, which the union says violates state law.
Better health care: Clemson, Prisma examine human factors
Clemson University faculty and Prisma Health clinicians have launched interdisciplinary research into system processes and procedures, or "human factors," that may impact patient experiences and job satisfaction among healthcare providers.
RWJBarnabas Health Programs, Clinician Honored by New Jersey Hospital Association
The New Jersey Hospital Association (NJHA) recognized two exceptional programs and one outstanding individual from the RWJBarnabas Health system at the 2026 Best at the Beach Awards, held last night at Ocean Place Resort & Spa in Long Branch. This annual awards program celebrates organizations that share NJHA’s commitment to improving the health of New Jersey.
New Global CARE-AI Framework Sets Standard for Responsible AI in Health Education and Care
An international team of researchers, clinicians, educators, ethicists, and patient partners has developed and validated the Health CARE-AI (Contextual, Accountable, Responsible, and Equitable Artificial Intelligence) Framework. Published in JMIR Medical Education, the landmark study provides an actionable, consensus-backed roadmap for the responsible integration of AI across the health care learning and practice continuum.
The current state and future promise of inpatient care inside patients’ homes: 5 things to know
The hospital-at-home model is known to please patients, clinicians and administrators alike. Why is it stuck in a holding pattern rather than flying high?
Electronic Health Record-Related Burnout: Implementing a Data-Driven Quality Improvement Intervention for Ambulatory Providers After an Electronic Health Record Transition
Background Electronic health records (EHRs) have improved healthcare delivery but have also introduced workflow inefficiencies that contribute to clinician burnout. After-hours EHR use has be...
This AI tool promises a 'second pair of eyes' to clinicians. Did patients benefit?
Medical workers in a Nairobi clinic used an AI tool to check their work. A new study evaluates the result.
This AI tool promises a 'second sight of eyes' to clinicians. Did patients benefit?
Medical workers in a Nairobi clinic used an AI tool to check their work. A new study evaluates the result.
Good riddance to bundled ‘global’ maternal care billing
New maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG writes.
Science Under the Sword of Damocles
By Sam Halpern, M.D. I have spent my working life in medicine as a clinician and a medical scientist. I have watched with awe as basic and applied medical science placed new and effective tools in…
Science Under the Sword of Damocles
By Sam Halpern, M.D. I have spent my working life in medicine as a clinician and a medical scientist. I have watched with awe as basic and applied medical science placed new and effective tools in…
Health insurers hedge on Trump-backed pledge to improve denials process
Patients, their advocates, and clinicians say little has improved.
UNM’s Medical Laboratory Sciences Program Trains the Experts Behind Modern Diagnosis
The Medical Laboratory Sciences (MLS) program at The University of New Mexico School of Medicine prepares students for one of health care’s most essential and often unseen roles – performing the laboratory testing that helps clinicians diagnose and treat...
Recall update: FDA now urging clinicians to return vascular device linked to 3 deaths
Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.
Three Clinicians Join Pozen-Commonwealth Fund Fellowship in Health Equity Leadership
The incoming fellows include two physicians and a nurse practitioner, all working to advance health equity across the U.S. healthcare system.
Informed Decision-Making with Healthcare Analytics
In healthcare, the byproducts of past challenges — data assets and innovation—are helping us envision a future where clinicians are well equipped to predict health outcomes and make informed decisions.
Striking Mass General Brigham home health clinicians picket outside headquarters: "We're at our breaking point"
While 4,000 Brigham and Women's nurses are locked out of the Boston hospital following a one-day strike, 450 home health clinicians are on day 3 of their week-long work stoppage.
Exploring key breakthroughs in VT ablation
Today's sophisticated mapping systems allow clinicians to visualize VT circuits with unprecedented detail.
ACC takes on DOAC use with new scientific statement
Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.
AI in Mental Health: Why Clinicians Need to Be in the Room
As clinicians, we learn not to be agreeable, we learn to challenge and sit in discomfort. We ask the hard questions underneath the one being asked. That is the work these tools are not yet built to do.
Children’s Hospital Los Angeles’ 2026 TSRI Science Day Highlights Advances in Cancer Biology
June 17 saw more than 400 scientists, clinicians, research staff, and other Children’s Hospital Los Angeles team members come together for The Saban Research Institute’s (TSRI) yearly symposium and poster session—Science Day 2026.
FDA approves surgical device for high-risk aortic procedures
The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed.
Healthcare AI's next big leap: Removing friction from clinical workflows
Rather than just adding more applications, one CMIO says, organizations should focus on using automation and intelligence to eliminate unnecessary steps, reduce clinician burden and streamline care delivery.
Despite Mayor Brandon Johnson campaign promise, 911 mental health response team flounders
Throughout his 2023 mayoral campaign, Brandon Johnson championed a progressive vision of sending teams of mental health clinicians instead of police officers to help people suffering from psychiatric emergencies. But since he took office…
Your health insurer shouldn’t decide your treatment plan. That’s what your doctor (and possibly AI) should be doing.
With a digital health record, clinicians and AI-driven diagnostic tools would be able to see your full health history — and then make better decisions.
Clinicians are making more money despite stagnant reimbursement. Guess how?
Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Hackensack Meridian Health Graduates Largest Number of Residents and Fellows Yet for Network
314 doctors continue their quest to be the best clinicians possible within New Jersey’s largest and most comprehensive health network
A federal judge orders an ICE detainee with mental illness released, finding her six-month detention unconstitutional
The ruling followed a hearing that exposed a sharp divide over how a Vermont prison's mental health providers, a corrections officer and outside clinicians assessed the woman’s mental illness, a dispute the judge did not resolve.
FDA clears AI software for flagging signs of vascular disease
The newly cleared software alerts clinicians when it detects a suspected vascular occlusion.
Researchers develop new 'emotionally aware' model for classifying mental health conditions
Researchers have developed a new "emotionally aware" AI-based model for classifying mental health conditions, which could help clinicians better diagnose patients' mental health conditions. The Emo-MHC ...
How employer-education partnerships are closing Chicago’s behavioral health workforce gap
Chicago’s behavioral health systems are under sustained pressure. The demand for services continues to rise, while the number of licensed clinicians entering the field has not kept the same pace.
Watkins honored with top national bone health award
MORGANTOWN, W.Va. – Colleen Watkins, M.D., a WVU Medicine rheumatologist, has been named the 2026 Andrew D. Bunta Own the Bone Clinician of the Year by the American Orthopaedic Association. Colleen Watkins, M.D. ...
UMG, The World’s Biggest Music Company, Is Investing In A Mental Health Ecosystem. Here’s How It Works
Universal Music Group's circle of shared care, access and economic responsibility that streamlines the process to obtaining mental health support from trained Amber Health clinicians is a blueprint for companies large and small.
Why Is Sexual Health Still Overlooked in Chronic Pain Care?
Experts urge clinicians to address intimacy and sexual well-being routinely, noting that chronic pain often affects relationships, self-esteem, and quality of life.
Pittsburgh plans to expand co-response program, pairing police with mental health clinicians
Medline recalls nearly 50K procedure kits, including many used by cardiologists
This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.
NHS staff battling wave of food supplement disinformation
Exclusive: Cancer charity says dispelling falsehoods gleaned from social media is now routine task for clinicians
Thomas Best, M.D., Ph.D., Earns ACSM Honor Award for Transforming Sports Injury Recovery
Dr. Thomas Best receives ACSM’s highest honor for pioneering sports injury recovery research and mentoring the next generation of clinicians.
WHO urges targeted action to strengthen emergency workforce capacities for shared health risks across the Asia-Pacific region
At a time when the world is more interconnected than ever, the World Health Organization (WHO) is disseminating a comprehensive regional analysis of shared health risks across Asia and the Pacific, urging Member States to invest in enhancing workforce capacities regionwide to mitigate these risks and ensure health systems are better prepared to anticipate, tackle and withstand a range of crises and shocks. Over 100 delegates from 49 countries and areas in the Asia-Pacific region reviewed results from the regional risk analysis during the WHO-led Asia Pacific Health Security Action Framework (APHSAF) Stakeholders Meeting in Malaysia. Synthesizing insights from 21 strategic risk assessments and more than 800 multisectoral experts, the regional analysis highlighted an urgent imperative: countries must proactively invest in emergency workforce preparedness to navigate a landscape where climate hazards, disease outbreaks and geophysical events increasingly overlap. These complex converging crises create devastating, compounding impacts on health systems and communities – reiterating the need for investing in a fit-for-purpose regional health workforce and multisectoral action.Key findings: an evolving risk landscape More than half of the participating countries ranked flooding, cyclones, dengue and pandemic-potential respiratory pathogens as being of high or very high risk, while antimicrobial resistance, landslides and gastroenteritis remain widespread concerns as well. “Given that 51% – over half – of these assessed hazards are deeply interconnected, isolated health interventions are no longer sufficient,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “Extreme weather events like cyclones and floods directly trigger subsequent disease outbreaks, while environmental degradation – driven by sea-level rise, coastal erosion and saltwater intrusion – fuels health risks across the Pacific. Mitigating these cascading risks requires unified, cross-sectoral action linking environmental, agricultural and public health policies to build true regional resilience.” Priority recommendations for action To address critical vulnerabilities, WHO calls on Member States in the Asia-Pacific region to urgently prioritize the following strategic actions: Bridge workforce capacity gaps. Embed and standardize emergency preparedness within academia to promote regional workforce interoperability. Foster multisectoral coordination. Address ad-hoc taskforce responses and fragmented surge support through formalized contingency plans and standard operating procedures that are frequently updated and tested. Secure sustainable financing for emergencies. Overcome systemic barriers to access dedicated funding for both immediate anticipatory actions and long-term emergency preparedness initiatives. Enable emergency-ready primary health care. Embed emergency management into public health workforce readiness planning. Ensure that emergency planning is inclusive. Establish clear pathways for inclusive emergency planning that actively involves communities most at risk and other vulnerable groups. Optimize communication. Update risk communication and community engagement strategies, aligning them with seasonal risk calendars. Elevating workforce readiness to meet regional health risks While the gaps identified are significant, the Asia-Pacific region possesses solid foundational pillars, including dedicated clinicians, laboratory staff, rapid response teams, emergency medical teams and extensive community networks. However, to adequately address the compounding nature of modern crises, the various components of the emergency workforce must collaborate cohesively. True resilience depends entirely on transforming this currently fragmented workforce into a highly trained, interconnected and rapidly deployable asset. To achieve this, WHO is actively advancing regional workforce capacities through the Global Health Emergency Corps initiative. This initiative – supported by the Gates Foundation and the Institute of Philanthropy – seeks to build a seamless network of emergency workforce across borders and sectors, ensuring that when a crisis strikes, a standardized, well-coordinated and trained workforce is immediately ready to respond. “Scaling up emergency workforce readiness is no longer optional,” said Dr Gina Samaan, Regional Emergency Director for WHO in the Western Pacific. “It is the definitive factor that will determine how effectively the Asia-Pacific region safeguards health and protects lives in an increasingly unpredictable future.” ____________________For more information, or to arrange media interviews, contact: Ara Johannes, WHO Western Pacific Health Emergencies Division: johannesa@who.int WHO Western Pacific Communications: wprocom@who.int
Tickets are now on sale for Business Report's Excellence in Health Care Awards
Tickets are on sale now for the inaugural Excellence in Health Care Awards, where Business Report will honor the leaders, clinicians and organizations strengthening care delivery across the Capital Region. Finalists and honorees will be celebrated at an awards dinner on Wednesday, Aug. 12, at the Crowne Plaza in Baton Rouge. The evening will bring […]
NUTRITION 2026: The leading source for the latest science
When it comes to nutrition, strong science is essential to navigating the myriad of choices that confront consumers, clinicians and policy
Vanderbilt Health and UAB partner to help more clinicians use genomic medicine in everyday care
The project will create a genomic eConsult service that allows clinicians to ask practical questions about genetic testing and interpretation.
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy, Visits AlphaLab Health in Pittsburgh - PA Department of Community & Economic Development
AlphaLab Health is a start-up accelerator collaboration created by Innovation Works and Allegheny Health Network to address healthcare problems experienced by clinicians and patients. Pennsylvania has always been a leader […]
Business Report's Excellence in Health Care Awards spotlight the leaders redefining care in the Capital Region
Some of the biggest names in health care will be honored this summer as Business Report hosts the inaugural Excellence in Health Care Awards, recognizing the leaders, clinicians and organizations strengthening care delivery across the Capital Region. Finalists and honorees will be celebration at an awards dinner on Wednesday, Aug. 12 at the Crowne Plaza […]
Business Report's Excellence in Health Care Awards spotlight the leaders redefining care in the Capital Region
Some of the biggest names in health care will be honored this summer as Business Report hosts the inaugural Excellence in Health Care Awards, recognizing the leaders, clinicians and organizations strengthening care delivery across the Capital Region. Finalists and honorees will be celebration at an awards dinner on Wednesday, Aug. 12 at the Crowne Plaza […]
Hospitalists Leading Health Informatics in the Digital Age
Technology in hospitals is changing quickly, having clinicians at the helm makes a difference.
Beyond BMI: New Score Stratifies Obesity Risk
BMI, while useful, is insufficient to identify patients at the highest risk for obesity-related complications. A new tool may help clinicians better stratify risk and target treatment.
WHO urges targeted action to strengthen emergency workforce capacities for shared health risks across the Asia-Pacific region
Kuala Lumpur, Malaysia, 11 June 2026 – At a time when the world is more interconnected than ever, the World Health Organization (WHO) is disseminating a comprehensive regional analysis of shared health risks across Asia and the Pacific, urging Member States to invest in enhancing workforce capacities regionwide to mitigate these risks and ensure health systems are better prepared to anticipate, tackle and withstand a range of crises and shocks. Over 100 delegates from 49 countries and areas in the Asia-Pacific region reviewed results from the regional risk analysis during the WHO-led Asia Pacific Health Security Action Framework (APSHAF) Stakeholders Meeting in Malaysia. Synthesizing insights from 21 strategic risk assessments and more than 800 multisectoral experts, the regional analysis highlighted an urgent imperative: countries must proactively invest in emergency workforce preparedness to navigate a landscape where climate hazards, disease outbreaks and geophysical events increasingly overlap. These complex converging crises create devastating, compounding impacts on health systems and communities - reiterating the need for investing in a fit-for-purpose regional health workforce and multisectoral action. Key findings: an evolving risk landscape More than half of the participating countries ranked flooding, cyclones, dengue and pandemic-potential respiratory pathogens as being of high or very high risk, while antimicrobial resistance, landslides and gastroenteritis remain widespread concerns as well. “Given that 51% - over half - of these assessed hazards are deeply interconnected, isolated health interventions are no longer sufficient,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “Extreme weather events like cyclones and floods directly trigger subsequent disease outbreaks, while environmental degradation - driven by sea-level rise, coastal erosion and saltwater intrusion - fuels health risks across the Pacific. Mitigating these cascading risks requires unified, cross-sectoral action linking environmental, agricultural and public health policies to build true regional resilience.” Priority recommendations for action To address critical vulnerabilities, WHO calls on Member States in the Asia-Pacific region to urgently prioritize the following strategic actions: Bridge workforce capacity gaps. Embed and standardize emergency preparedness within academia to promote regional workforce interoperability. Foster multisectoral coordination. Address ad-hoc taskforce responses and fragmented surge support through formalized contingency plans and standard operating procedures that are frequently updated and tested. Secure sustainable financing for emergencies. Overcome systemic barriers to access dedicated funding for both immediate anticipatory actions and long-term emergency preparedness initiatives. Enable emergency-ready primary health care. Embed emergency management into public health workforce readiness planning. Ensure that emergency planning is inclusive. Establish clear pathways for inclusive emergency planning that actively involves communities most at risk and other vulnerable groups. Optimize communication. Update risk communication and community engagement strategies, aligning them with seasonal risk calendars. Elevating workforce readiness to meet regional health risks While the gaps identified are significant, the Asia-Pacific region possesses solid foundational pillars, including dedicated clinicians, laboratory staff, rapid response teams, emergency medical teams and extensive community networks. However, to adequately address the compounding nature of modern crises, the various components of the emergency workforce must collaborate cohesively. True resilience depends entirely on transforming this currently fragmented workforce into a highly trained, interconnected and rapidly deployable asset. To achieve this, WHO is actively advancing regional workforce capacities through the Global Health Emergency Corps initiative. This initiative - supported by the Gates Foundation and Institute of Philanthropy - seeks to build a seamless network of emergency workforce across borders and sectors, ensuring that when a crisis strikes, a standardized, well-coordinated and trained workforce is immediately ready to respond. “Scaling up emergency workforce readiness is no longer optional,” said Dr Gina Samaan, Regional Emergency Director for WHO in the Western Pacific. “It is the definitive factor that will determine how effectively the Asia-Pacific region safeguards health and protects lives in an increasingly unpredictable future.” For more information, or to arrange media interviews, contact: Ara Johannes, WHO Western Pacific Health Emergencies Division: johannesa@who.int WHO Western Pacific Communications: wprocom@who.int
Microsoft and Mayo Clinic partner to build healthcare AI model
Mayo Clinic will own the model, which will be trained on de-identified patient data and initially deployed for use by its clinicians
Top 6 worries about healthcare AI among clinicians and patients in 2026
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
NVIDIA, Foxconn and Taiwan Medical Centers Bring Agentic and Physical AI to ‘Healthy Taiwan’
NVIDIA, Foxconn and Taiwan Medical Centers Bring Agentic and Physical AI to ‘Healthy Taiwan’ Foxconn is deploying NVIDIA AI across Taiwan’s leading medical centers, transitioning from using individual AI tools to coordinated AI agent workforces that help clinicians reason, document and orchestrate care. News Summary: Foxconn is deploying NVIDIA AI across Taiwan’s leading medical centers, transitioning from using individual AI tools to coordinated AI agent workforces that help clinicians reason,
Indoor Fragrances: Are Overlooked Health Risks Growing?
Daily exposure to indoor fragrances is drawing growing concern as clinicians report rising allergies, asthma, and air quality problems linked to scented products.
FDA sees potential in new AI software for monitoring heart failure patients
The software-only platform helps clinicians keep track of patients when they are at their most vulnerable.
Neuroinfectious Diseases Research Workshop: Advancing Translational Science and Clinical Research Innovation
The Neuroinfectious Diseases Research Workshop will be a two-day scientific meeting designed to accelerate research, foster collaboration, and build capacity in the field of neurological infections. Hosted at the NIH Neuroscience Center (NSC, Executive Boulevard), this meeting will bring together clinician-scientists, laboratory investigators, translational researchers, government partners, and trainees committed to advancing understanding of neuroinfectious
LA’s program that diverts mental health crisis calls away from police to expand
Trained clinicians with the city’s Unarmed Model of Crisis Response have handled over 20,000 calls since 2024.
Inside Optum Health's push to make AI practical for clinicians
A phased rollout of AI-powered chart summarization is reducing administrative burdens while testing how healthcare organizations can responsibly scale artificial intelligence.
419 FW and 151 ANG Advocates tackle mental health: briefs Utah clinicians
As mental health professionals from across Utah gathered for the University of Utah College of Social Work’s Continuing Education Unit Institute on May 13, behavioral health leaders from the military community took the virtual stage to shed light on a critical but often misunderstood population: Reservists and Guardsmen.
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Global Mitochondrial Health Summit 2026: How nutraceuticals power cellular energy for longevity
Mitochondrial health is now recognized as vital for overall well-being and longevity. Leading clinicians, researchers, and educators on the emerging science behind the cellular powerhouse will be meeting on June 26 at the inaugural Global Mitochondrial Health Summit, hosted by Kaneka Ubiquinol.Ahead of the event in Sydney, Australia, Nutrition Insight speaks with Dr. Kazunori Hosoe, scientist and researcher at Kaneka Corporation, about advancements in mitochondrial science, gaps in nutraceutical products, and how the industry can communicate complex science with consumer-friendly messaging.
Managing the Second Victim in Healthcare
After a patient safety incident, clinicians need confidential, empathetic, and nonpunitive support — not blame — to prevent burnout and silence, reduce repeat errors, and improve reporting and care quality.
Science for Living: Managing type 2 diabetes in pregnancy
As more people enter pregnancy with type 2 diabetes, researchers and clinicians at UMass Chan are studying new ways to improve care before, during and after pregnancy.
A doctor shortage is coming. AI could be the only realistic fix
With 86,000 clinicians missing by 2036 and physicians spending less than a third of time on patients, AI is a hopeful fix for medicine's structural issue.
Ebola Disease Outbreak in the Democratic Republic of the Congo and Uganda
Advisory to clinicians, public health practitioners, and travelers about a new outbreak of Ebola.
Parkinson’s Health Fair Connects Patients, Caregivers, and Future Clinicians
Student-led Midwestern University Clinics event provides hands-on support and resources
PFA has been a game-changer for heart patients—but there are still risks
Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.
Right medicine, right person: Jacintha Sivarajah on science with purpose
“All medicines have side effects, but it's just about trying to minimize the impact through providing the information patients and clinicians need or finding other ways to mitigate that impact.” — Jacintha Sivarajah
CEPHR: Advancing Patient Care Through Environmental Health Research
The Center for Environment, Place and Health Research connects clinicians with mapping tools and other real-world data resources to help guide medical insights.
Becoming an AI-Forward Health System
From AI skeptic to transformation leader, Ken Kawamoto, MD, PhD, MHS, is guiding U of U Health toward tools that ease clinician burden and deliver more responsive, patient-centered care.
MAPS Announces Dates for Psychedelic Science 2027; Early Bird Registrations Now Open
Early bird registration is now open for Psychedelic Science 2027, taking place May 3–7, 2027, in Denver, Colorado.Early bird pricing offers discounted registration in limited quantities to the world’s leading psychedelic conference.Psychedelic Science 2027 to convene 8,000+ researchers, clinicians, policymakers, advocates, and cultural leaders from around the globe. DENVER, May 13, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced that early bird
School of Medicine graduates ready to make positive changes in health care
Vanderbilt University School of Medicine graduates were challenged to maintain perspective: What is routine for the clinician is extraordinary for the patient.
Colorado is short thousands of mental health workers. A nonprofit is working to close the gap.
Part of the problem starts before clinicians ever see a patient.
AI chatbots struggle with subtle mental health cues
AI models miss the cues clinicians catch, a new benchmark finds.
Vanderbilt Health to open Acute Care Center
Access to the new center’s services will be limited to existing adult Vanderbilt Health patients referred by Vanderbilt Health clinicians. The center will not accept walk-up patients or referrals from providers outside the Vanderbilt Health system.
Fitness wearable Whoop to offer on-demand clinician access to U.S. users
Whoop is introducing on-demand clinician access and AI-powered health guidance, largely included in the price of membership.
TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
Independent Evidence Reviews Overturn Insurer Denials Of Healthcare Coverage
Policy experts suggest reform of prior authorization that would require coverage decisions be supported solely by evidence being reviewed by independent clinicians.
2026 Fellows Advancing Women's Health Research in Africa
Fellows from 11 countries represent a diverse group of researchers, clinicians, biotechnologists, and innovators committed to women's health research in Africa.
Kettering Health restructures its post-implant heart failure care with new EHR integration
The Epic-connected platform, which monitors CardioMEMS implants, has gained the Ohio health system big efficiencies, such as a 77% reduction in time spent by clinicians on post-implant activities.
Neuroinfectious Diseases Research Workshop: Advancing Translational Science and Clinical Innovation
The Neuroinfectious Diseases Research Workshop will be a two-day scientific meeting designed to accelerate research, foster collaboration, and build capacity in the field of neurological infections. Hosted at the NIH Neuroscience Center (NSC, Executive Boulevard), this meeting will bring together clinician-scientists, laboratory investigators, translational researchers, government partners, and trainees committed to advancing understanding of neuroinfectious
For Catholic therapists, accompanying clients in pain guides mental health care
For Mental Health Awareness Month in May, NCR spoke with Catholic clinicians who emphasized accompaniment, careful discernment around spiritual language, and a commitment to seeing clients as whole persons.
Vanderbilt Health clinicians seek to improve care for those with traumatic brain injuries
CBIS training covers the cognitive, psychological and social consequences of brain injury; behavioral approaches for managing challenging behaviors and promoting positive skills; and techniques for effectively working with families of individuals with brain injury.
How Reid Health uses AI to save time, improve retention and elevate patient experience
Through a partnership with HelloCare.ai, Reid Health began using Abridge, a generative AI system, to document clinician-patient conversations.
Brooklyn College Hosts Second Annual Perinatal Mental Health Summit in Brownsville
Daylong convening brings together 200 clinicians, researchers, and community leaders to advance equitable, trauma-informed care for parents, infants, and families.
Columbus Issue 5 wants to send clinicians, not cops, to some 911 calls
Columbus Issue 5 aims to change how Columbus handles mental health crises. Voters will decide whether to send clinicians, not police.
MIT researchers find self-organizing “pencil beam” laser could help scientists design brain-targeted therapies
After a surprising discovery that overcomes a longstanding problem in fiber optics, MIT researchers demonstrated a biomedical imaging technique that is faster and more precise than other methods, which could help scientists and clinicians study new brain therapies.
AMA calls for regulatory crackdown on chatbots, wellness AI
In this edition of STAT Health Tech: OpenAI's targets clinicians, AMA's call for regulatory crackdown, and bargain-basement telehealth visits.
Pearl of the week: Why most AI projects fail in health care
Learn why workflow design and clinician engagement are critical for successful AI implementation.
Colorado state legislators must recognize EMS is essential
By Dusty A. Johnson Currently, emergency medical services (EMS) clinicians such as EMTs and paramedics are not listed as essential in Colorado, and that is not OK. A few weeks ago, the Colorado House of Representatives unambiguously passed a bill to designate emergency medical services as an essential service. My bill is long overdue in […]
Primary Care Training Expands Access to Pediatric Mental Healthcare for Anxiety and Depression
Training and coaching can equip primary care clinicians to take on a larger role in pediatric mental healthcare.
Jacobs Institute of Women’s Health Launches New Initiative to Strengthen Postpartum Care | Milken Institute School of Public Health | The George Washington University
Initiative, funded by The Commonwealth Fund, will convene leading clinicians, researchers and policy experts to define and advance high-quality postpartum care nationwide
A global consensus establishes a basis for measuring and improving gut health
While “gut health” is becoming a popular term, mainly in media and marketing claims but also in the clinical context, researchers have not yet nailed down a definition. Now, a global group of 13 scientists and clinicians updates a consensus definition of gut health and implications from bench to bedside.
Return to Sport Rates Following Total Knee Arthroplasty
A recent study shows that understanding timelines and key factors could help clinicians give tailored advice and set realistic expectations for their patients undergoing TKA.
New Webinar Series Explores Relationship Between Microbiome and Health
The free virtual series is open to students, researchers, clinicians and anyone from the public with an interest in microbiome science.
Sexual Healthcare for Cancer Survivors
Pelin Batur, MD, advocates for clinicians to help patients with cancer by prioritizing the sexual-health treatments supported by strong data.
Migration can influence cardiovascular risk profiles, study shows
A new study shows that migration from Mexico to the United States can influence cardiovascular risk profiles. The study's findings are important for clinicians who serve immigrant populations and who ...
Mount Sinai to integrate OpenEvidence AI enterprise-wide
By embedding OpenEvidence directly into its Epic electronic health records, the New York health system aims to change how its clinicians access health data at the point of care to improve patient outcomes.
Washington doctors are sounding alarm on cannabis health effects, survey shows
More than a decade after recreational cannabis was legalized in Washington, a new survey of health care providers suggests many clinicians are concerned about its effects on patients’ mental health.